BRCA1‐associated‐protein‐1 inactivated melanocytic tumours: characterisation of the clinicopathological spectrum and immunohistochemical expression pattern of preferentially expressed antigen in melanoma
2024

Characterization of BAP1 Inactivated Melanocytic Tumors

Sample size: 65 publication Evidence: moderate

Author Information

Author(s): Yitong Xu, Alejandro A Gru, Thomas Brenn, Katharina Wiedemeyer

Primary Institution: University of Calgary

Hypothesis

The study aims to characterize the clinicopathological features and immunohistochemical expression of BAP1 inactivated melanocytic tumors in a large patient cohort.

Conclusion

BAP1 inactivated melanocytic tumors are more common in sporadic cases and behave indolently, despite concerning cytological atypia.

Supporting Evidence

  • BAP1 inactivated tumors were identified in a cohort of 65 cases.
  • Patients with BAP1 germline mutations presented at a younger age and often had multiple tumors.
  • PRAME immunohistochemistry showed negative or weakly patchy positive staining in all tumors.

Takeaway

This study looks at a type of skin tumor that usually grows slowly and doesn't turn into cancer, even though it can look scary under a microscope.

Methodology

The study involved reviewing histopathological slides, performing immunohistochemistry for PRAME, and obtaining clinical follow-up from patient records.

Limitations

The study is limited to a specific geographic area and may not represent the global prevalence of BAP1 inactivated tumors.

Participant Demographics

The study included 38 patients (31 females and 7 males) with a mean age of 39.6 years.

Digital Object Identifier (DOI)

10.1111/his.15318

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication